Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation | Zendy

Jorn Brouwer | Zendy; Vincent J. Nijenhuis | Zendy; Ronak Delewi | Zendy; Renicus S. Hermanides | Zendy; Wouter Holvoet | Zendy; Christophe Dubois | Zendy; Peter Frambach | Zendy; Bernard De Bruyne | Zendy; Gert K. van Houwelingen | Zendy; Jan A.S. Van der Heyden | Zendy; Petr Toušek | Zendy; Frank van der Kley | Zendy; Ian Buysschaert | Zendy; Carl E. Schotborgh | Zendy; Bert Ferdinande | Zendy; Pim van der Harst | Zendy; John Roosen | Zendy; Joyce Peper | Zendy; Frederick W. Thielen | Zendy; Leo Veenstra | Zendy; Dean R.P.P. Chan Pin Yin | Zendy; Martin J. Swaans | Zendy; Benno J. Rensing | Zendy; Arnoud W.J. van ’t Hof | Zendy; Leo Timmers | Zendy; Johannes C. Kelder | Zendy; Pieter R. Stella | Zendy; Jan Baan | Zendy; Jurriën M. ten Berg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

Author(s) -

Jorn Brouwer,

Vincent J. Nijenhuis,

Ronak Delewi,

Renicus S. Hermanides,

Wouter Holvoet,

Christophe Dubois,

Peter Frambach,

Bernard De Bruyne,

Gert K. van Houwelingen,

Jan A.S. Van der Heyden,

Petr Toušek,

Frank van der Kley,

Ian Buysschaert,

Carl E. Schotborgh,

Bert Ferdinande,

Pim van der Harst,

John Roosen,

Joyce Peper,

Frederick W. Thielen,

Leo Veenstra,

Dean R.P.P. Chan Pin Yin,

Martin J. Swaans,

Benno J. Rensing,

Arnoud W.J. van ’t Hof,

Leo Timmers,

Johannes C. Kelder,

Pieter R. Stella,

Jan Baan,

Jurriën M. ten Berg

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2017815

Subject(s) - medicine , aspirin , clopidogrel , myocardial infarction , stroke (engine) , randomized controlled trial , confidence interval , surgery , cardiology , mechanical engineering , engineering

The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been well studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research